Magnolia Capital Advisors’s DexCom DXCM Stock Holding History

Magnolia Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$675K	Buy	10,741 +485	+5%	+$33.8K	0.13%	177
2025 Q4	$681K	Sell	10,256 -1,886	-16%	-$122K	0.14%	147
2025 Q3	$817K	Buy	12,142 +88	+0.7%	+$6.96K	0.21%	120
2025 Q2	$1.05M	Sell	12,054 -679	-5%	-$53.2K	0.26%	103
2025 Q1	$870K	Buy	12,733 +1,386	+12%	+$113K	0.24%	107
2024 Q4	$882K	Buy	11,347 +3,359	+42%	+$249K	0.23%	111
2024 Q3	$536K	Buy	7,988 +3,313	+71%	+$272K	0.27%	93
2024 Q2	$530K	Buy	+4,675	New	+$591K	0.3%	82

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Magnolia Capital Advisors's DXCM Position: Q1 2026 in Review

Magnolia Capital Advisors increased its DexCom (DXCM) stake by 4.7% in Q1 2026, buying an estimated $33.8K and bringing the position to 10,741 shares worth $675K. The position accounts for 0.13% of the portfolio, ranked #177.

Magnolia Capital Advisors first reported a position in DXCM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.05M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Magnolia Capital Advisors held 10,741 shares of DexCom worth $675K as of Q1 2026.
Magnolia Capital Advisors bought 485 DexCom shares in Q1 2026, an estimated $33.8K.
DexCom made up 0.13% of Magnolia Capital Advisors's portfolio in Q1 2026, its #177 holding.
Magnolia Capital Advisors first reported a position in DexCom in Q2 2024 and has held it in 8 quarters since.
Magnolia Capital Advisors's DexCom position peaked at $1.05M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.